The UC Davis MIND Institute’s new Distinguished Lecturer Series lineup includes renowned experts on race and autism, maternal mental health, ADHD interventions and more.
A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
An innovative pathway program led by the UC Davis School of Medicine and Kaiser Permanente to boost the number of Latino health professionals has helped hundreds of undergraduate students pursue careers in medicine.
